Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|March 1, 2018
Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's diseaseDiego Grassi, Shannon Howard, Minghai Zhou, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Potent and Selective Urea-Based ROCK Inhibitors and Their Effects on Intraocular Pressure in RatsYan Yin, Michael D Cameron, Li Lin, et al.Journal of Medicinal Chemistry|October 7, 2008
Discovery of substituted 4-(pyrazol-4-yl)-phenylbenzodioxane-2-carboxamides as potent and highly selective Rho kinase (ROCK-II) inhibitorsYangbo Feng, Yan Yin, Amiee Weiser, et al.Bioorganic & Medicinal Chemistry Letters|November 8, 2008
Chroman-3-amides as potent Rho kinase inhibitorsYen Ting Chen, Thomas D Bannister, Amiee Weiser, et al.Bioorganic & Medicinal Chemistry Letters|October 19, 2011
Discovery and optimization of indoles and 7-azaindoles as Rho kinase (ROCK) inhibitors (part-I)Sarwat Chowdhury, E Hampton Sessions, Jennifer R Pocas, et al.Bioorganic & Medicinal Chemistry Letters|October 25, 2011
Discovery and optimization of indole and 7-azaindoles as Rho kinase (ROCK) inhibitors (part-II)E Hampton Sessions, Sarwat Chowdhury, Yan Yin, et al.Bioorganic & Medicinal Chemistry Letters|November 11, 2008
Benzimidazole- and benzoxazole-based inhibitors of Rho kinaseE Hampton Sessions, Yan Yin, Thomas D Bannister, et al.Journal of Biomolecular Screening|January 30, 2008
Comparison of miniaturized time-resolved fluorescence resonance energy transfer and enzyme-coupled luciferase high-throughput screening assays to discover inhibitors of Rho-kinase II (ROCK-II)Thomas Schröter, Dmitriy Minond, Amiee Weiser, et al.ACS Chemical Neuroscience|June 14, 2011
Small Molecule c-jun-N-terminal Kinase (JNK) Inhibitors Protect Dopaminergic Neurons in a Model of Parkinson's DiseaseJeremy W Chambers, Alok Pachori, Shannon Howard, et al.Bioorganic & Medicinal Chemistry Letters|February 20, 2010
The development of benzimidazoles as selective rho kinase inhibitorsE Hampton Sessions, Michael Smolinski, Bo Wang, et al.Pageof 4